Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
This study wants to find out if taking a 1mg minoxidil tablet every day is a safe and effective way to treat a common type of female hair loss called androgenetic alopecia. Researchers will compare this tablet to a 2% minoxidil solution that you put on your skin, and also to a dummy tablet or cream (a placebo) that contains no active medicine. The main goals are to see if the tablet works as well as the skin solution, or even better than the dummy treatment, and to make sure it's safe for patients. The study lasts about 36 weeks and involves different groups getting various combinations of these treatments.
Auf einen Blick
Worum geht es in dieser Studie?
This study is about a type of hair loss common in women, called androgenetic alopecia. It's often linked to hormones. Researchers want to see if a daily 1mg tablet of minoxidil can help grow hair and make it thicker. Minoxidil is already used in a solution you put on your scalp, and this study aims to find out if a tablet form is just as helpful, or even more so, for this kind of hair loss.
To do this, the study will compare a daily minoxidil tablet against two other treatments. One is the familiar 2% minoxidil solution applied to the skin. The other is a "placebo," which looks exactly like the real medicine but has no active ingredients. This helps researchers understand if any changes are truly due to the minoxidil or something else.
Ultimately, the main goal is to understand if the minoxidil tablet is both effective and safe for women with this type of hair loss. The study is a "Phase III" trial, which means it's a larger study designed to confirm the results of earlier, smaller studies before a new treatment can be considered for wider use.
Wichtige Erkenntnisse
- This study is testing a minoxidil tablet for female hair loss.
- It compares the tablet to a skin solution and a dummy treatment.
- The study lasts about 36 weeks and requires regular visits and checks.
- You won't know if you're getting the active drug or a placebo.
- You must be a woman aged 18 or over with specific hair loss symptoms and generally good health.
Wer könnte berechtigt sein?
This study is looking for women aged 18 or older who are generally healthy. You would need to have been diagnosed with female androgenetic alopecia, which means a noticeable thinning of hair, particularly on the top and crown of your head, as described by a specific hair loss scale.
It's important that you don't have any serious health problems, especially heart conditions, or any skin conditions on your scalp that might interfere with the study. If you could become pregnant, you'll need to have negative pregnancy tests and agree to use highly effective birth control throughout the study and for a short time afterwards. Also, your hair colour needs to stand out enough against your scalp for photos to be taken easily.
Finally, you should be willing to keep your hairstyle and hair care routine the same during the study, as well as your body hair removal habits. You'd also need to attend all scheduled appointments and follow the study instructions carefully.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie eine Frau im Alter von 18 Jahren oder älter?
- Have you been diagnosed with female pattern hair loss (androgenetic alopecia) on your scalp?
- Are you generally healthy, without heart problems or other significant illnesses?
- If you can get pregnant, are you willing to use effective birth control throughout the study?
- Are you able to attend regular appointments and follow study instructions?
Was beinhaltet die Teilnahme?
If you join this study, it will last up to 36 weeks (about 8 to 9 months). You'll be randomly placed into one of three groups. One group will take the minoxidil tablet and use a dummy skin solution. A second group will take a dummy tablet and use the 2% minoxidil skin solution. The third group will take a dummy tablet and use a dummy skin solution.
You'll visit the study centre 5 times during this period for check-ups and observations. There will also be 2 phone calls. At your visits, doctors will take photos of your hair to check for growth, measure your blood pressure, pulse, and body temperature. You'll also have a general health check, blood tests, urine tests, and an ECG (heart tracing). They will also look for any unwanted hair growth on your body. You'll be asked daily to record any side effects, new medications, or procedures. If you could become pregnant, you'll have regular pregnancy tests.
Potenzielle Risiken und Vorteile
Standorte (13)
- Fachklinik Bad Bentheim Klinisches StudienzentrumVerifizierte PostleitzahlBad Bentheim, Germany· Rekrutierung
- CRC - Charité Universitätsmedizin Berlin Clinical Research Center for Hair and Skin ScienceVerifizierte PostleitzahlBerlin, Deutschland· Rekrutierung
- emovis by Futuremeds GmbHVerifizierte PostleitzahlBerlin, Deutschland· Rekrutierung
- Rosenpark Reasearch GmbHVerifizierte PostleitzahlDarmstadt, Germany· Noch nicht rekrutiert
- Privatpraxis Dr. Hilton & PartnerVerifizierte PostleitzahlDüsseldorf, Germany· Beendet
- Klinik für Dermatologie, Venerologie und Allergologie - Universitätsmedizin FrankfurtVerifizierte PostleitzahlFrankfurt, Deutschland· Rekrutierung
- Dermaticum -Dr. med. Mario Bittar und KollegenVerifizierte PostleitzahlFreiburg im Breisgau, Germany· Rekrutierung
- Eurofins bioskin - Research Center DermatologyVerifizierte PostleitzahlHamburg, Deutschland· Rekrutierung
- Klinische Forschung Karlsruhe GmbHVerifizierte PostleitzahlKarlsruhe, Germany· Rekrutierung
- Siteworks - Prüfzentrum LohneVerifizierte PostleitzahlLöhne, Germany· Aktiv, aber nicht rekrutierend
- Zentrale Studienkoordination für innovative Dermatologie (ZiD) Klinik für Hautkrankheiten Universitätsklinikum Münster (UKM)Verifizierte PostleitzahlMünster, Germany· Zurückgezogen
- Haut-und Lasercentrum - Dr. Tanja Fischer und KollegenVerifizierte PostleitzahlPotsdam, Germany· Rekrutierung
Häufige Fragen
What is androgenetic alopecia?
It's a common type of hair loss in women, often called female pattern baldness, which is thought to be linked to hormones.
Was ist ein 'Placebo'?
A placebo is a dummy treatment that looks like the real medicine but contains no active ingredients. It helps researchers compare how well the actual medicine works.
Wie lange wird die Studie dauern?
The study will last for up to 36 weeks, which is about 8 to 9 months.
Will I know if I'm getting the real medicine or the dummy treatment?
No, this is a 'double-blind' study, meaning neither you nor your doctor will know which treatment you are receiving until after the study is over. This helps keep the results fair.
What kind of tests will I have during the study?
You'll have hair photos, blood tests, urine tests, ECGs, and general health checks, including blood pressure and temperature measurements.
Wie Sie mehr erfahren können
Ana López-Ballesteros
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.